JO2238B1 - Isoindolin-1-one- glucokinase activators - Google Patents

Isoindolin-1-one- glucokinase activators

Info

Publication number
JO2238B1
JO2238B1 JO2001193A JOP20010193A JO2238B1 JO 2238 B1 JO2238 B1 JO 2238B1 JO 2001193 A JO2001193 A JO 2001193A JO P20010193 A JOP20010193 A JO P20010193A JO 2238 B1 JO2238 B1 JO 2238B1
Authority
JO
Jordan
Prior art keywords
isoindolin
glucokinase activators
glucokinase
activators
diabetes
Prior art date
Application number
JO2001193A
Other languages
Arabic (ar)
Inventor
ريتشارد جورتين كيفن
Original Assignee
اف. هوفمان- لاروش أيه جي‏
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اف. هوفمان- لاروش أيه جي‏ filed Critical اف. هوفمان- لاروش أيه جي‏
Application granted granted Critical
Publication of JO2238B1 publication Critical patent/JO2238B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
JO2001193A 2000-12-13 2001-12-09 Isoindolin-1-one- glucokinase activators JO2238B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25527300P 2000-12-13 2000-12-13

Publications (1)

Publication Number Publication Date
JO2238B1 true JO2238B1 (en) 2004-10-07

Family

ID=40418787

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2001193A JO2238B1 (en) 2000-12-13 2001-12-09 Isoindolin-1-one- glucokinase activators

Country Status (4)

Country Link
AR (1) AR035405A1 (en)
EC (1) ECSP034651A (en)
GT (1) GT200100247A (en)
JO (1) JO2238B1 (en)

Also Published As

Publication number Publication date
GT200100247A (en) 2002-07-31
ECSP034651A (en) 2003-07-25
AR035405A1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
EG24358A (en) Isoindolin-1-one glucokinase avtivators
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
MXPA05008406A (en) Phenylacetamides and their use as glucokinase modulators.
MY136764A (en) Indole-3-carboxamides as glucokinase (gk) activators
JO2180B1 (en) Trans olefinic glucokinase activators
AU2002213925A1 (en) Use of glp-1 and flp-2 peptides for treatment of bone disorders
WO2001083465A3 (en) Alkynyl phenyl heteroaromatic glucokinase activators
PT1311504E (en) TETRAZOLYL-PHENYL ACETAMIDES ACTIVATORS OF GLUCOQUINASE
YU9404A (en) Peptide-based multimeric targeted contrast agents
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
SG148034A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
ZA200400313B (en) Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine.
PT1435991E (en) Use of aplidine for the treatment of pancreatic cancer
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
RS20050733A (en) Benzo/1,2,5/thiadiazole compounds
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
JO2238B1 (en) Isoindolin-1-one- glucokinase activators
MXPA04000418A (en) Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines.
MX2007004040A (en) Novel use of -sympathomimetics having a 2-imidazoline structure.
UA70017A (en) Method for conservative treatment of chronic tonsillitis in adults
MXPA04003673A (en) Use of aplidine for the treatment of pancreatic cancer.
ZA200107918B (en) The treatment of rubber.
UA32255A (en) Method for treating diabetes mellitus
ZA200301030B (en) Treatment of the insulin resistance syndrome.